Patient characteristics
| Patient characteristics | Diagnosis | |
|---|---|---|
| axSpA (n=22, 61%) | PsA (n=13, 39%) | |
| Male:female ratio | 21:1 | 3:11 |
| Concomitant csDMARD, n (%), proportion by drug, n (%) drug | 10 (45), 10 (100) MTX | 8 (62), 7 (86) MTX and 1 (14) HCQ |
| Previous biologic drug: | ||
| Adalimumab, n (%) | 2 (9) | 2 (15) |
| Etanercept, n (%) | 1 (5) | 2 (15) |
axSpA = Axial spondyloarthritis; csDMARD = conventional synthetic disease-modifying antirheumatic drug; HCQ = hydroxychloroquine; MTX = Methotrexate; PsA = psoriatic arthritis.